XGNEXAGEN INC.vs its industry peers
A metric-by-metric comparison of EXAGEN INC. against SIC 8071 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| XGNEsta | $189M#6 | — | 15.4x#7 | 2.8x#3 | 19.7%#2 | -32.0%#3 | -21.1%#3 | -163.3%#6 | -134.4%#5 | 2#2 | -14.5%#3 | — |
| FTRE | $1.9B#1 | — | 3.6x#5 | 0.7x#2 | 1.0%#4 | -200.6%#5 | -32.0%#4 | -188.7%#7 | -61.9%#4 | — | 98.6%#2 | — |
| PSNL | $1.7B#2 | — | 7.3x#6 | 24.7x#6 | -17.7%#5 | 0.0%#2 | -126.4%#6 | -34.6%#4 | -55.0%#3 | — | 174.0%#1 | — |
| BLLN | $1.2B#3 | 100.4x#1 | 2.2x#3 | 3.8x#5 | 100.0%#1 | 117.9%#1 | 5.3%#1 | 1.4%#1 | 33.9%#1 | — | — | — |
| LMRI | $1.1B#4 | — | 1.8x#2 | — | — | — | — | 0.0%#2 | — | — | — | — |
| CSTL | $1.1B#5 | — | 2.3x#4 | 3.1x#4 | 3.7%#3 | -232.4%#6 | -12.4%#2 | -5.1%#3 | -10.2%#2 | 5#1 | — | — |
| BGLC | $4M#7 | — | 0.6x#1 | 0.6x#1 | -21.9%#6 | -86.7%#4 | -39.9%#5 | -38.4%#5 | — | — | -71.8%#4 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 8071). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. Esta tabla agotó el tiempo durante su construcción, por lo que cubre parte del grupo; los rangos son solo dentro de las filas mostradas y se completará en breve. Table built 2026-09-16.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice